Core research areas
The core research areas of the HMI include but are not limited to longevity, Alzheimer’s disease, Parkinson’s disease, dementia, infectious diseases, metabolic disorders, and cancers, as well as the evaluating the spread of antibiotic resistance and ways to overcome this process.
Microbiome, cancer, longevity
Increasing evidence indicates a key role for the microbiome in human longevity, and in the development of a variety of cancers and poorly treated diseases, including neurodegenerative disorders. However, the human microbiome has yet to be fully characterized, and a clear understanding of its composition remains elusive.
Role of HMI
We at the Human Microbiology Institute are dedicated to characterizing the composition of the microbiota among different groups of people to identify new pathogens and to advance our understanding of how these organisms influence human health and longevity and contribute to human diseases.
HMI’s unique methods
Our research groups have already developed unique methods of studying the human microbiome, and are now focused on expanding our knowledge of its role in numerous poorly treated pathologies, which may ultimately give rise to personalized microbiota studies and therapies. In addition, we are in the process of studying the role of the microbiota in diseases that are more prevalent in the Jewish community.
Original theory for novel medicines
The HMI’s scientists are also conducting research, and have developed original theories regarding the role of the microbiome in human longevity and age-related diseases, with the principal goal of translating this knowledge into novel medicines.
We know that our unique scientific approach will translate into the development of innovative drug candidates for numerous poorly treated diseases.